Get Blog Posts Directly In Your Inbox

Your email:

Most Popular Posts

Posts by Month

Browse by Tag

Follow BBCR

Current Articles | RSS Feed RSS Feed

Challenges in Clinical Trial for Small Patient Populations

Could Seamless Adaptive Designs Advance Clinical Trial Design?

How Good is FAST?

Longer Stretch to the Finish Line

Cost vs. Value: Can We Have Both?

What’s in a name?

Refocusing and Regrouping

The Art of Practicing Personalized Medicine

Strategic Innovation in Trial Design drives Precision Medicine

The End of The Beginning in Novel Clinical Study Strategies

Moving Towards Risk-based Monitoring in Clinical Investigations

Join us at the ACRP 2012 Global Conference and Exhibition

“Reveal-ution” in Clinical Trials

SCIO helps early stage biotech company valuation

Biomarkers in Drug Development "highly commended" by the BMA

Gene Therapy for Type 1 Diabetes Targets Treatment of Autoimmunity

Getting More Drugs Approved for Rare Diseases

Innovation in Rare Diseases

Is there room in the Pharma industry for small niche providers?

Understanding Personalized Medicine

BBCR BIO International Convention review

Monitoring Patient Safety during Clinical Trials

Innovative Strategies Address Risks Related to Multiple Sclerosis Treatments

Trial Protocol Innovations Critical to Efficient Clinical Development

On Genetic Disorders, Diseases and the future of Pharmacogenetics

Save the Date! Innovation in Biomarker Strategy & Precision Medicine

Boomer Generation Ages: Are We Ready?

Smart Clinical Development for an Innovative Case Solution

EMEA to 2015: Enhancing Patient Safety

Addressing the Challenges of Clinical Trial Globalization

Cure for Alzheimer’s Disease: A light at the end of the tunnel?

Belysta: the first drug approved to treat Lupus in 50 years.

Unmet medical needs: Lupus Erythematosus Systemic (SLE)

2011 Biotech Global Stage - Will you be there?

Pharmaceutical Industry Needs Big Innovations In Drug Development

Breakthrough in Personalized Medicine in Cancer Treatment

Two Big Trends In The Clinical Research Industry

Progress in Neglected Disease Drug Development

How are we spending money to treat neglected diseases

Are Genetic Diseases the key to Personalized and Stratified Medicines?

Genetic Disorders and Diseases

Rare Diseases - Recent Trends

What are Data Safety Monitoring Boards (DSMB)?

Foreign Clinical Trials - Key Challenge and Solution

Do you have a Clinical Development Plan?

Two Key Mistakes To Avoid Before Starting A Clinical Trial

Streamlining Clinical Trial Strategies

How Clinical Trial Planning and Strategy can save you time and money

Personalized Medicines: Are we ready for the revolution?

Positioning Biomedical Companies for Strategic Competitive Advantage